ETC
IONS icon

Exchange Traded Concepts’s Ionis Pharmaceuticals IONS Stock Holding History

Exchange Traded Concepts’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Buy
33,941
+12,847
+61% +$1.01M 0.02% 538
2025
Q4 		$1.67M Buy
21,094
+3,024
+17% +$228K 0.01% 631
2025
Q3 		$1.18M Buy
18,070
+9,268
+105% +$452K 0.01% 716
2025
Q2 		$348K Buy
8,802
+5,558
+171% +$182K ﹤0.01% 974
2025
Q1 		$97.9K Buy
3,244
+3,066
+1,722% +$100K ﹤0.01% 1171
2024
Q4 		$6.22K Sell
178
-17
-9% -$635 ﹤0.01% 1354
2024
Q3 		$7.81K Buy
+195
New +$9.07K ﹤0.01% 1298
2024
Q2 		– Sell
-82
Closed -$3.56K – 1262
2024
Q1 		$3.56K Buy
+82
New +$3.91K ﹤0.01% 1213
2021
Q1 		– Sell
-2,248
Closed -$127K – 1095
2020
Q4 		$127K Buy
+2,248
New +$112K 0.01% 649
2020
Q2 		– Sell
-5,184
Closed -$245K – 811
2020
Q1 		$245K Hold
5,184
– – 0.13% 197
2019
Q4 		$313K Buy
+5,184
New +$309K 0.07% 164

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Exchange Traded Concepts's IONS Position: Q1 2026 in Review

Exchange Traded Concepts increased its Ionis Pharmaceuticals (IONS) stake by 61% in Q1 2026, buying an estimated $1.01M and bringing the position to 33,941 shares worth $2.55M. The position accounts for 0.02% of the portfolio, ranked #538.

Exchange Traded Concepts first reported a position in IONS in Q4 2019 and has held it in 11 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Exchange Traded Concepts held 33,941 shares of Ionis Pharmaceuticals worth $2.55M as of Q1 2026.
  • Exchange Traded Concepts bought 12,847 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.01M.
  • Ionis Pharmaceuticals made up 0.02% of Exchange Traded Concepts's portfolio in Q1 2026, its #538 holding.
  • Exchange Traded Concepts first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 11 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.